[On-Demand Webinar] Advancing Obesity Clinical Development: Emerging Strategies for Next‑Gen Trials
With global recognition of obesity as a complex, chronic disease impacting over one billion people, advancements in obesity clinical development...
World Obesity Day 2025: Recent Developments and the Road Ahead
In January 2025, the FDA released updated guidance titled “Obesity and Overweight: Developing Drugs and Biological Products for Weight Reduction.” The FDA...
Medpace Expands Rare Disease & Metabolic Medical Leadership Team
Medpace is pleased to announce the addition of a new rare disease and metabolic expert, Dr. Loren Peña, to the medical leadership team.
Key Learnings from European Congress on Obesity and ENDO
Discover key learning from the European Congress on Obesity and ENDO 2024 conferences.
Medpace Recognizes World Obesity Day
March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the...
[Webinar] Optimizing Study Execution in Obesity Clinical Trials: Considerations for Recruitment and Retention
In this webinar, hear from Medpace medical and operational experts as they address these unique challenges in the recruitment and retention of obesity participants and…